Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+45.0%
5Y CAGR+41.4%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+45.0%/yr
Annual compound
5Y CAGR
+41.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $816.29M | +48.0% |
| 2024 | $551.48M | +63.4% |
| 2023 | $337.57M | +26.2% |
| 2022 | $267.53M | -3.0% |
| 2021 | $275.90M | +91.3% |
| 2020 | $144.25M | +313.4% |
| 2019 | $-67.61M | +2.5% |
| 2018 | $-69.33M | -185.6% |
| 2017 | $81.00M | +197.3% |
| 2016 | $-83.21M | - |